| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.18 | 0.001 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.099 | 0.003 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.004 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.13 | 0.004 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.095 | 0.005 |